MCID: GNT003
MIFTS: 53

Genital Herpes malady

Categories: Infectious diseases, Reproductive diseases

Aliases & Classifications for Genital Herpes

About this section

Aliases & Descriptions for Genital Herpes:

Name: Genital Herpes 11 50 38 2 13 68
Herpes Genitalis 11 39
Genital Herpes Simplex 11
 
Virus-Genital Herpes 11
Herpes Genitalia 11
Venereal Herpes 11

Classifications:



External Ids:

Disease Ontology11 DOID:8704
ICD9CM32 054.1, 054.10
MeSH39 D006558
NCIt45 C14364

Summaries for Genital Herpes

About this section
MedlinePlus:38 Genital herpes is a sexually transmitted disease (std) caused by a herpes simplex virus (hsv). it can cause sores on your genital or rectal area, buttocks, and thighs. you can get it from having vaginal, anal, or oral sex with someone who has it. the virus can spread even when sores are not present. mothers can also infect their babies during childbirth. symptoms of herpes are called outbreaks. you usually get sores near the area where the virus has entered the body. the sores are blisters which break and become painful, and then heal. sometimes people do not know they have herpes because they have no symptoms or very mild symptoms. the virus can be more serious in newborn babies or in people with weak immune systems. repeat outbreaks are common, especially during the first year. over time, you get them less often and the symptoms become milder. the virus stays in your body for life. there are tests that can diagnose genital herpes. there is no cure. however, medicines can help lessen symptoms, decrease outbreaks, and lower the risk of passing the virus to others. correct usage of latex condoms can reduce, but not eliminate, the risk of catching or spreading herpes. nih: national institute of allergy and infectious diseases

MalaCards based summary: Genital Herpes, also known as herpes genitalis, is related to herpes simplex and herpes simplex encephalitis, and has symptoms including fever, pelvic pain and pruritus. An important gene associated with Genital Herpes is ACKR1 (Atypical Chemokine Receptor 1 (Duffy Blood Group)), and among its related pathways are OX40 Pathway and Cytokines and Inflammatory Response. The drugs valacyclovir and acyclovir sodium have been mentioned in the context of this disorder. Affiliated tissues include genital system, rectum and testes, and related mouse phenotypes are immune system and digestive/alimentary.

Disease Ontology:11 A herpes simplex that results in infection located in genital system, or located in rectum, has material basis in Human herpesvirus 1 or has material basis in Human herpesvirus 2, which is transmitted by sexual contact. The infection has symptom sores, has symptom fever, and has symptom swollen glands.

Wikipedia:71 Genital herpes is a genital infection caused by the herpes simplex virus (HSV). Most individuals... more...

Related Diseases for Genital Herpes

About this section

Diseases related to Genital Herpes via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 102)
idRelated DiseaseScoreTop Affiliating Genes
1herpes simplex11.6
2herpes simplex encephalitis10.9
3tubular renal disease-cardiomyopathy syndrome10.3IL10, IL4
4asymptomatic neurosyphilis10.3IL10, IL4
5lagophthalmos10.3IL10, IL4
6ceroid lipofuscinosis, neuronal, 310.2IL10, IL4
7diabetic angiopathy10.2IL10, IL4
8conidiobolomycosis10.2IL10, IL4
9tungiasis10.2IL10, IL4
10vestibule of mouth cancer10.2IL10, IL4
11hidradenitis suppurativa10.2CCL5, IL10
12congenital heart defects, hamartomas of tongue, and polysyndactyly10.2IL10, IL4
13goat milk allergy10.2IL10, IL4
14indian plum allergy10.2IL10, IL4
15nguyen syndrome10.2IL10, TLR2
16centronuclear myopathy 510.2IL10, IL4
17cerebral primitive neuroectodermal tumor10.2CCL5, IL4
18osteodysplasty precocious of danks mayne and kozlowski10.2CCL5, IL10, IL4
19amyotrophic lateral sclerosis-parkinsonism/dementia complex10.2CCL5, IL10
20primary optic atrophy10.2CCL5, TLR2
21nonspecific interstitial pneumonia10.2ACKR1, IL10, IL4
22apricot allergy10.2CCL5, IL4
23pulmonary tuberculosis10.1CCL5, IL10, IL4
24spontaneous ocular nystagmus10.1CCL5, IL10, IL4
25lipid storage disease10.1CCL5, IL10, IL4
26acute chest syndrome10.1CCL5, IL10, IL4
27non-gestational choriocarcinoma10.1CCL5, IL10, TBX21
28luminal breast carcinoma10.1IL18, IL4
29nervous system cancer10.1CCL5, IL10, IL4
30facial paralysis10.1IL10, IL18
31cutaneous fibrous histiocytoma10.1CCL5, IL4
32mediastinum neurofibroma10.1CCL5, IL10, IL4
33exophthalmos10.1CCL5, IL10, IL4
34congenital hypothyroidism10.1IL10, IL4, TLR2
35abnormal retinal correspondence10.1IL10, IL4, TLR2
36thymus adenosquamous carcinoma10.1CCL5, IL10, IL4
37peripheral artery disease10.1IL10, IL4, TLR2
38dengue hemorrhagic fever10.1IL10, IL4, TLR2
39inflammatory bowel disease 210.1IL10, IL4, TLR2
40liver inflammatory pseudotumor10.1IL10, IL4, TLR2
41hallucinogen dependence10.1IL10, IL4, TLR2
42keratomalacia10.1IL10, IL4, TLR2
43foodborne botulism10.1IL10, IL4, TLR2
44trachea leiomyoma10.1CCL5, IL4
45mansonelliasis10.1CCL5, IL10, TLR2
46optic nerve hypoplasia10.1ACKR1, IL10, TLR2
47erythematosquamous dermatosis10.1IL10, IL4, TLR2
48acute myeloid leukemia with recurrent genetic anomaly10.1IL10, IL18, IL4
49atrial septal defect 610.1IL10, IL4, TLR2
50rectum squamous cell carcinoma10.0CCL5, IL10, TLR2

Comorbidity relations with Genital Herpes via Phenotypic Disease Network (PDN):


Acute Cystitis

Graphical network of the top 20 diseases related to Genital Herpes:



Diseases related to genital herpes

Symptoms & Phenotypes for Genital Herpes

About this section

Symptoms:

 11
  • sores
  • fever
  • swollen gl

UMLS symptoms related to Genital Herpes:


fever, pelvic pain, pruritus

MGI Mouse Phenotypes related to Genital Herpes according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053878.2ACKR1, APOE, CCL5, IL10, IL18, IL4
2MP:00053818.0APOE, IL10, IL18, IL4, T, TBX21
3MP:00107717.5APOE, IL10, IL18, IL4, T, TLR2

Drugs & Therapeutics for Genital Herpes

About this section

Drugs for Genital Herpes (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 53)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
MetronidazoleapprovedPhase 4486443-48-14173
Synonyms:
1-(2-hydroxy-1-ethyl)-2-methyl-5-nitroimidazole
1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(beta-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Oxyethyl)-2-methyl-5-nitroimidazole
1-(β-ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(β-hydroxyethyl)-2-methyl-5-nitroimidazole
1-(β-oxyethyl)-2-methyl-5-nitroimidazole
1-Hydroxyethyl-2-methyl-5-nitroimidazole
2-(2-methyl-5-nitroimidazol-1-yl)ethanol
2-Methyl-5-nitro-1-imidazoleethanol
2-Methyl-5-nitroimidazole-1-ethanol
2-methyl-1-(2-hydroxyethyl)-5-nitroimidazole
2-methyl-3-(2-hydroxyethyl)-4-nitroimidazole
2-methyl-5-nitroimidazole-1-ethanol
443-48-1
46461_FLUKA
46461_RIEDEL
69198-10-3 (mono-hydrochloride)
99616-64-5
AB00052046
AC-10556
AC1L1HKS
AC1Q2P2Z
AKOS000269646
APMN
ARONIS24285
Acromona
Anagiardil
Apo-Metronidazole
Arilin
Atrivyl
BAS 02983617
BAY-5360
BCBcMAP01_000184
BIDD:GT0107
BPBio1_000004
BRD-K52020312-001-05-2
BRN 0611683
BSPBio_000002
BSPBio_002031
Bayer 5360
Bexon
Bio-0694
CAS-443-48-1
CB-01-14 MMX
CCRIS 410
CHEBI:39845
CHEBI:6909
CHEMBL137
CID4173
CONT
CPD000058175
Caswell No. 579AA
Clont
D00409
DB00916
Danizol
Deflamon
Deflamon-wirkstoff
DivK1c_000007
EINECS 207-136-1
EPA Pesticide Chemical Code 120401
Efloran
Elyzol
Entizol
Eumin
FLAGYL I.V. RTU IN PLASTIC CONTAINER
Flagemona
Flagesol
Flagil
Flagyl
Flagyl (TN)
Flagyl 375
Flagyl Er
Flagyl I.V.
Flagyl I.V. RTU
Flegyl
Florazole
Fossyol
Giatricol
Ginefla vir
Gineflavir
HMS1568A04
HMS1920N19
HMS2051G07
HMS2090B19
HMS2091F14
HMS500A09
HMS547C19
HSDB 3129
I14-0667
IDI1_000007
IDR-90105
KBio1_000007
KBio2_001515
KBio2_004083
KBio2_006651
KBio3_001531
KBioGR_000559
KBioSS_001515
Klion
Klont
LS-1264
M0924
M1547_SIGMA
M3761_FLUKA
M3761_SIGMA
M9036_SIGMA
METRO I.V
METRONIDAZOLE USP
MLS000028590
MLS000758286
Maybridge1_001999
Meronidal
Methronidazole
Methyl-5-nitroimidazole-1-ethanol
 
Metric
Metric 21
Metro Cream
Metro Gel
Metro I.V.
Metro I.V. In Plastic Container
MetroCream
MetroGel
MetroGel-Vaginal
MetroLotion
Metrodzhil
Metrogel-vaginal (TN)
Metrogyl
Metrolag
Metrolyl
Metromidol
Metronidaz
Metronidazol
Metronidazol [INN-Spanish]
Metronidazole (JP15/USP/INN)
Metronidazole Benzoate
Metronidazole Monohydrochloride
Metronidazole Phosphoester
Metronidazole [USAN:INN:BAN:JAN]
Metronidazole in Plastic Container
Metronidazolo
Metronidazolo [DCIT]
Metronidazolum
Metronidazolum [INN-Latin]
Metrotop
Metrozine
Metryl
Mexibol
Mexibol 'silanes'
MolPort-000-141-892
MolPort-002-502-101
Monagyl
Monasin
NCGC00016446-01
NCGC00016446-02
NCGC00022059-03
NCGC00022059-04
NCGC00022059-05
NCIOpen2_000337
NIDA
NINDS_000007
NSC 50364
NSC 69587
NSC-50364
NSC50364
NSC69587
Nalox
Nidagel
Noritate
Noritate (TN)
Novonidazol
Orvagil
Prestwick0_000081
Prestwick1_000081
Prestwick2_000081
Prestwick3_000081
Prestwick_334
Protostat
RP 8823
RP-8823
Rathimed
Rosased
S1907_Selleck
SAM001247010
SBB041018
SC 10295
SMP1_000189
SMR000058175
SPBio_000666
SPBio_001941
SPECTRUM1500412
STK177359
Sanatrichom
Satric
Spectrum2_000883
Spectrum3_000506
Spectrum4_000060
Spectrum5_001289
Spectrum_001035
Takimetol
Trichazol
Trichex
Tricho cordes
Tricho-gynaedron
Trichocide
Trichomol
Trichomonacid 'pharmachim'
Trichopal
Trichopol
Tricocet
Tricom
Tricowas B
Trikacide
Trikamon
Trikojol
Trikozol
Trimeks
Trivazol
UNII-140QMO216E
Vagilen
Vagimid
Vandazole
Vertisal
WLN: T5N CNJ A2Q B1 ENW
WLN: T5N CNJA2Q B1 ENW
WLN: T6NTJ DQ ANU1- ET5N CNJ A1 BNW
Wagitran
ZERO/004064
ZINC00113442
Zadstat
Zidoval
giniflavir
metronidazole
neo-Tric
2
Tenofovirapproved, investigationalPhase 4759147127-20-6464205
Synonyms:
(R)-9-(2-Phosphonomethoxypropyl)adenine
(R)-9-(2-Phosphonylmethoxypropyl)adenine
(R)-9-(2-phosphonomethoxypropyl)adenine
(R)-PMPA
147127-20-6
206184-49-8
AC-760
AC1LA9BO
Anh. tenofovir
Anhydrous tenofovir
Apropovir
CHEBI:45809
CHEMBL483
CID464205
D,L-Tenofovir
DB00300
GNA & Tenofovir
GS 1275
GS 1278
GS1278
 
HHA & Tenofovir
KS-5021
MolPort-003-850-411
NCGC00167535-01
PMPA
PMPA-(R)
Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Galanthus nivalis agglutinin (GNA)
Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Hippeastrum hybrid agglutinin( HHA)
Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- (9CI)
Phosphonic acid, [[2-(6-amino-9H-purin-9
S1401_Selleck
TDF
TFV
Tenefovir
Tenofovir
Tenofovir (anh.)
Tenofovir disoproxil
Tenofovir disoproxil fumarate
UNII-99YXE507IL
Viread
Viread, Tenofovir
[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid
3
FamciclovirapprovedPhase 4, Phase 319104227-87-43324
Synonyms:
1,3-Propanediol, 2-(2-(2-amino-9H-purin-9-yl)ethyl)-, diacetate (ester)
104227-87-4
2-(2-(2-Amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate (ester)
2-(2-(2-amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate
2-(acetoxymethyl)-4-(2-amino-4,5-dihydro-9H-purin-9-yl)butyl acetate
2-[(acetyloxy)methyl]-4-(2-amino-9H-purin-9-yl)butyl acetate
2-[2-(2-amino-9H-purin-9-yl)ethyl]-1,3-propanediol diacetate
9-(4-acetoxy-3-(acetoxymethyl)but-1-yl)-2-aminopurine
9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine
AC-11064
AC1L1FOB
Anti-Farnesyl Rabbit pAb
BRD-K45033733-001-02-3
BRL 42810
BRL-42810
BSPBio_003489
Bio-0039
C14H19N5O4
CHEBI:4974
CHEMBL880
CID3324
CPD000466375
D00317
DB00426
Diacetyl 6-deoxy-9-(4-hydroxy-3-hydroxymethyl-but-1-yl)guanine
FCV
Famciclovir
Famciclovir (JAN/USAN/INN)
Famciclovir [USAN:BAN:INN]
Famciclovirum
Famciclovirum [INN-Latin]
Famvir
Famvir (TN)
HMS1922L09
 
HMS2051G22
HMS2090G10
HMS2093K12
I03-0096
IN1338
KBio2_000946
KBio2_003514
KBio2_006082
KBio3_002709
KBioGR_001162
KBioSS_000946
LS-120147
MLS000759505
MLS001424115
MolPort-003-666-602
NCGC00095133-01
NCGC00095133-02
NCGC00095133-03
Oravir
S2467_Selleck
SAM001246732
SMR000466375
SPBio_001202
SPECTRUM1505201
STK623204
Spectrum2_001101
Spectrum3_001675
Spectrum4_000611
Spectrum5_001548
Spectrum_000466
UNII-QIC03ANI02
ZINC01530635
[2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate
acetic acid 2-acetoxymethyl-4-(2-amino-purin-9-yl)-butyl ester
famciclovir
4Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 122062
5Antiviral AgentsPhase 4, Phase 3, Phase 2, Phase 19967
6valacyclovirPhase 4, Phase 3, Phase 2, Phase 1106
7AcyclovirPhase 4, Phase 3, Phase 2, Phase 1183
8Antiparasitic AgentsPhase 42199
92-AminopurinePhase 4, Phase 327
10Antiprotozoal AgentsPhase 42051
11Reverse Transcriptase InhibitorsPhase 41913
12Anti-HIV AgentsPhase 43162
13Anti-Retroviral AgentsPhase 43296
14Nucleic Acid Synthesis InhibitorsPhase 44962
15AntimetabolitesPhase 4, Phase 312054
16
HalofantrineapprovedPhase 31869756-53-237393
Synonyms:
(+-)-Halofantrine hydrochloride
(1)-Halofantrine
1,3-Dichloro-.alpha.-[2-(dibutylamino)ethyl]-6- (trifluoromethyl)-9-phenathrenemethanol
1,3-Dichloro-.alpha.-[2-(dibutylamino)ethyl]-6-(trifluoromethyl)-9-phenanthrene-methanol
1,3-Dichloro-6-trifluoromethyl-9-(3-(dibutylamino)-1-hydroxypropyl)phenanthrene HCl
1,3-Dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-9-phenanthrenemethanol hydrochloride
1,3-Dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)phenanthren-1-methanol hydrochloride
1-(1,3-Dichloro-6-trifluoromethyl-9-phenanthryl)-3-(di-n-butylamino)propanol hydrochloride
1-(1,3-dichloro-6-trifluoromethyl-9-phenanthryl)-3-di(n-butyl)aminopropanol HCl
106927-11-1
3-(Dibutylamino)-1-(1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl)propan-1-ol hydrochloride
3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol
3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol hydrochloride
36167-63-2
66051-63-6
69756-53-2
9-(3-(dibutylamino)-1-hydroxypropyl)-1,3-dichloro-6-(trifluoromethyl)phenanthrene hydrochloride
9-Phenanthrenemethanol, 1,3-dichloro-.alpha.-[2-(dibutylamino)ethyl]-6-(trifluoromethyl)-(1)
9-Phenanthrenemethanol, 1,3-dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-, hydrochloride
9-Phenanthrenemethanol, 1,3-dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-,hydrochloride
AB00514703
AC-481
AC1L1XMK
AC1L1XMN
AC1Q4K45
BPBio1_001366
BSPBio_001241
C26H30Cl2F3NO.HCl
CHEBI:252728
CHEMBL1107
CHEMBL1200901
CID37392
CID37393
D02485
DB01218
EINECS 252-895-4
FT-0082696
 
HALOFANTRINE HYDROCHLORIDE
HMS1571O03
Halfan
Halfan (TN)
Halofantrina
Halofantrina [INN-Spanish]
Halofantrine
Halofantrine HCl
Halofantrine Hydrochloride [USAN]
Halofantrine [USAN]
Halofantrine [Usan]
Halofantrine hydrochloride (USAN)
Halofantrino
Halofantrino [Spanish]
Halofantrinum
Halofantrinum [INN-Latin]
I14-2822
LS-102675
LS-187198
MLS002154111
MolPort-005-940-418
MolPort-005-942-171
NCGC00179250-01
NCI60_002593
Prestwick0_001031
Prestwick1_001031
Prestwick2_001031
Prestwick3_001031
SK&F-102866
SMR001233418
SPBio_003092
UNII-H77DL0Y630
UNII-Q2OS4303HZ
WR 171,699
WR 171669
WR-171,669
WR-171669
WR-171699
dl-WR 171669
17interferonsPhase 3, Phase 22175
18KrestinPhase 3, Phase 2210
19Monophosphoryl lipid APhase 319
20Protective AgentsPhase 37443
21Interferon InducersPhase 3, Phase 2294
22Radiation-Protective AgentsPhase 3480
23Antibiotics, AntitubercularPhase 3, Phase 1, Phase 27180
24Adjuvants, ImmunologicPhase 3, Phase 22554
25VaccinesPhase 3, Phase 2, Phase 16611
26Anti-Bacterial AgentsPhase 3, Phase 1, Phase 211226
27Aluminum sulfatePhase 392
28
Ganciclovirapproved, investigationalPhase 215382410-32-03454
Synonyms:
106931-35-5
107910-75-8 (mono-hydrochloride salt)
2'-NDG
2'-Nor-2'-deoxyguanosine
2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol
2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one
2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one
2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one
2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one
2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol
2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one
2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one
2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol
2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one
2-amino-9-(2-Hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone
2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone
2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one
2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one
82410-32-0
86357-12-2
9-((1,3-Dihydroxy-2-propoxy)methyl)guanine
9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine
9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE
9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine
9-[(1,3-dihydroxy-2-propoxy)methyl]guanine
96551-29-0
AC-12604
AC1L1FZ2
AC1Q52OB
AKOS004119898
BB_NC-1042
BIDD:GT0783
BIOLF-62
BPBio1_000877
BSPBio_000797
BW 759
BW 759U
BW-759U
BW-795
BW-B 759U
Biolf 62
CAS-82410-32-0
CCRIS 9212
CHEBI:465284
CHEMBL182
CID3454
CPD000058324
Citovirax
Cymevan
Cymeven
Cymevene
Cytovene
Cytovene (TN)
Cytovene-IV
D00333
DB01004
DRG-0018
EU-0100539
 
G 2536
G2536_SIGMA
GA2
GANCICLOVIR SODIUM
GCV & 1110U81
GCV & MSL
Ganciclovir
Ganciclovir & C34-dgA immunotoxin
Ganciclovir & D5-dgA immunotoxin
Ganciclovir (JAN/USP/INN)
Ganciclovir [USAN:INN:BAN:JAN]
Ganciclovirum
Ganciclovirum [Latin]
Gancyclovir
Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)- and MSL, neutralizing monoclonal antibody
HHEMG
HMS1570H19
HMS2090K08
HSDB 6512
Hydroxyacyclovir
I07-0010
IN1478
LS-73939
Lopac-G-2536
Lopac0_000539
MB3795
MLS000028481
MLS001077349
MolPort-000-758-398
MolPort-002-507-301
NCGC00015471-01
NCGC00015471-02
NCGC00015471-03
NCGC00015471-06
NCGC00093928-01
NCGC00093928-02
NCGC00168567-01
PDSP1_000816
PDSP2_000803
Prestwick0_000839
Prestwick1_000839
Prestwick2_000839
Prestwick3_000839
Prestwick_1068
RS-21592
SAM002548936
SMP2_000038
SMR000058324
SPBio_002718
ST-605
STK801910
UNII-P9G3CKZ4P5
Virgan
Vitrasert
Vitrasert (TN)
ZINC00001505
Zirgan
ganciclovir
nchembio.87-comp3
29
Imiquimodapproved, investigationalPhase 214099011-02-657469
Synonyms:
1-(2-Methylpropyl)-1H-imidazole[4,5-c]quinoline-4-amine
1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine
1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine
1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
1-isobutyl-1H-imidazo(4,5-c)quinolin-4-amine
1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
3M Brand of Imiquimod
4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline
4-Amino-1-isobutyl-1H-imidazo[4,5-c]quinoline
99011-02-6
AC-529
AC1L1N2I
AC1Q4YO9
Aldara
Aldara (TN)
Aldara, Imiquimod
BB_SC-2107
BIDD:GT0859
Beselna
C056493
CHEBI:36704
CHEMBL1282
CID57469
D02500
DB00724
DZ-2636
FT-0080222
HMS2090M14
 
I06-0624
I06-2289
I0747
I5159_SIGMA
IMIQUIMOD
Imiquimod
Imiquimod (JAN/USAN/INN)
Imiquimod [USAN:INN]
Imiquimod acetate
Imiquimodum
LS-178395
MLS000083577
MTD-39
MolPort-002-507-845
NCGC00070736-02
NSC369100
R 837
R-837
S 26308
S-26308
S1211_Selleck
SMR000048307
STK583860
TL8006059
TMX-101
UNII-P1QW714R7M
ZINC19632912
Zartra
Zyclara
imiquimod
30Ganciclovir triphosphatePhase 2153
31Anti-Infective Agents, LocalPhase 21880
32Freund's AdjuvantPhase 2105
33
QS 21Phase 240141256-04-4
Synonyms:
 
Stimulon
34Pharmaceutical SolutionsPhase 1, Phase 28192
35LecithinNutraceuticalPhase 274
36
Methadoneapproved33076-99-34095
Synonyms:
(+)-Methadone
(+-)-Methadone
(+/-)-Methadone
(+/-)-Methadone hydrochloride
(+/-)-Tussal
(-)-(R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
(-)-Methadone
(6R)-Methadone
(R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
(R)-6-(Dimethylamino)-4,4-diphenyl-3-hetpanone
(S)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
(±)-methadone
1095-90-5 (hydrochloride)
297-88-1
3-14-00-00278 (Beilstein Handbook Reference)
3-14-00-00279 (Beilstein Handbook Reference)
3-Hetpanone, 6-(dimethylamino)-4,4-diphenyl-, (R)- (9CI)
5653-80-5
6-(Dimethylamino)-4,4-diphenyl-3-heptanone dl-mixture
6-(dimethylamino)-4,4-diphenylheptan-3-one
6-Dimethylamino-4,4-diphenyl-3-heptanone
6-dimethylamino-4,4-di(phenyl)heptan-3-one
6S-Methadone
76-99-3
A 4624
AC-16055
AC1L1HEG
AC1Q2RLW
AN 148
AN-148 (*Hydrochloride*)
Adanon
Adanon hydrochloride
Adolan
Algidon
Algolysin
Algovetin
Althose
Althose hydrochloride
Amidon
Amidone
BRN 3213667
BRN 3213668
BRN 3213669
Biscuits
Butalgin
C07163
CHEBI:6807
CHEMBL651
CID4095
D08195
DB00333
DEA No. 9250
DL-Methadone hydrochloride
Depridol
Dextromethadone
Diaminon
Diaminon hydrochloride
DivK1c_000963
Dl-Methadone
Dollies
Dolly
Dolofin hydrochloride
Dolohepton
Dolophin
Dolophin hydrochloride
Dolophine
Dolophine (*Hydrochloride*)
Dolophine HCL
EINECS 200-996-9
Fenadon
Fenadone
 
Fenadone (*Hydrochloride*)
HSDB 3119
Heptadon
Heptadone
Heptadone (*Hydrochloride*)
Heptanon
Heptanon (*Hydrochloride*)
Heptanon (pharmaceutical)
Hoechst 10820
Hoescht 10820 (*Hydrochloride*)
IDI1_000963
K 174
KBio1_000963
Ketalgin
Ketalgin hydrochloride
L-(+)-Methadone
L-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
L-Polamidon
L000874
LS-74485
LS-74486
LS-74487
Levometadona
Levometadona [INN-Spanish]
Levomethadone [INN]
Levomethadonum
Levomethadonum [INN-Latin]
Levothyl
Mecodin
Mephenon
Metadona
Metadona [INN-Spanish]
Metadona [Spanish]
Metadone
Metadone [DCIT]
Metasedin
Methadon
Methadona
Methadona [Spanish]
Methadone (BAN)
Methadone HCL
Methadone HCL Intensol
Methadone M
Methadone [INN:BAN]
Methadone hydrochloride
Methadonum
Methadonum [INN-Latin]
Methadonum [Latin]
Methadose
Methaquaione
Miadone
Moheptan
MolPort-001-785-650
NINDS_000963
Phenadone
Phenadone (*Hydrochloride*)
Phenadone hydrochloride
Physeptone
Polamidon
Polamidone
Polamivet
Racemic methadone
S-(+)-Methadone
Sedo-Rapide
Tussol
UNII-UC6VBE7V1Z
Westadone
d-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
d-Methadone
dl-Methadone
l-Methadone
l-Polamivet
methadone
37
Guaifenesinapproved, vet_approved64193-14-13516
Synonyms:
3-(2-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-propanediol-1,2
3-O-Methoxyphenoxypropane 1:2-diol
Actifed C
Aeronesin
Amonidren
Amonidrin
Aresol
Benylin-E
Bronchol
Glycerin ether
Glycerin guaiacolate
Glycero-guaiacol ether
Glycerol a-(2-methoxyphenyl) ether
Glycerol a-(O-methoxyphenyl)ether
Glycerol a-guaiacyl ether
Glycerol a-guiacyl ether
Glycerol a-monoguaiacol ether
Glycerol guaiacolate
Glycerol mono(2-methoxyphenyl) ether
Glycerol-a-guajakolether
Glycerol-alpha-guajakolether
Glyceryl guaiacol
Glyceryl guaiacol ether
Glyceryl guaiacolate
Glyceryl guaiacolate ether
Glyceryl guaiacyl ether
Glyceryl guaicolate
Glyceryl guiacolate
 
Glycerylguaiacol
Guaiacol glycerol ether
Guaiacol glyceryl ether
Guaiacolglicerinetere
Guaiacuran
Guaiacurane
Guaiacyl glyceryl ether
Guaiamar
Guaianesin
Guaicol glycerine ether
Guaicol glyceryl ether
Guaifenesin
Guaifenesine
Guaiphenesin
Guaiphenesine
Guaiphesin
Hustosil
Methoxypropanediol
Methphenoxydiol
Metossipropandiolo
O-Methoxyphenyl glyceryl ether
Organidin NR
Pneumomist
Propanosedyl
Reduton
Robitussin
a-Glyceryl guaiacol ether
a-Glyceryl guaiacolate ether
alpha-Glyceryl guaiacol ether
alpha-Glyceryl guaiacolate ether
guaiphenesin
p-Cresyl acetate
38
Heroinapproved, illicit115561-27-35462328
Synonyms:
(5α,6α)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester)
3,6-Diacetylmorphine
7,8-Dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate
Diacetylmorphine
 
Diamorphine
O,O'-Diacetylmorphine
Smack
diacetylmorphine
diamorphine
39
Emtricitabineapproved, investigational457143491-57-060877
Synonyms:
(-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(-)-(2R,5S)-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(-)-.beta.-L-FTC
(-)-2',3'-Dideoxy-5-fluoro-3'-thiacytidine
(-)-2'-Deoxy-5-fluoro-3'-thiacytidine
(-)-FTC
(-)-beta-2',3'-Dideoxy-5-fluoro-3'-thiacytidine
(-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine
(-)-cis-4-amino-5-Fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
(-)-cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
(2R-cis)-4-Amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone
(2R-cis)-4-amino-5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone
.beta.-L-(-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine
143491-54-7
143491-57-0
145213-48-5
2',3',5-FTC
2',3'-Dideoxy-5-fluoro-3'-thiacytidine
2'-Deoxy-5-fluoro-3'-oxa-4'-thiocytidine
2'-Deoxy-5-fluoro-3'-thiacytidine
2-FTC
3'-Thia-2'.3'-dideoxy-5-fluorocytidine
4-Amino-5-fluoro-1-((2R,5S)-2-hydroxymethyl-[1,3]oxathiolan-5-yl)-1H-pyrimidin-2-one
4-Amino-5-fluoro-1-[(2R,5S)-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone
4-amino-5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one
4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)[1,3]oxathiolan-5-yl]cytosine
524W91
AC1L1U3I
AC1Q4KUB
BW 1592
 
BW 524W91
BW-524W91
BW524W91
C122114
C12599
C8H10FN3O3S
CHEBI:31536
CHEMBL885
CID60877
Coviracil
Coviracil(TM)
D01199
DB00879
DRG-0208
Emtricitabin
Emtricitabina
Emtricitabine
Emtricitabine (JAN/USAN/INN)
Emtricitabinum
Emtriva
Emtriva (TN)
Emtriva(TM)
FT-0080009
HMS2089I05
HSDB 7337
LS-135838
LS-173184
NCGC00164564-01
RCV
Racivir
SBB066061
TL8000958
UNII-G70B4ETF4S
ZINC03629271
beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine
dOTFC
emtricitabine
40Respiratory System Agents4997
41Peripheral Nervous System Agents23689
42Narcotics3646
43Antitussive Agents542
44Chlorpheniramine, phenylpropanolamine drug combination641
45Analgesics11733
46Analgesics, Opioid3238
47Central Nervous System Depressants13403
48Raltegravir Potassium292
49Integrase Inhibitors418
50Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination248

Interventional clinical trials:

(show top 50)    (show all 101)
idNameStatusNCT IDPhase
1Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black PatientsCompletedNCT00477334Phase 4
2A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.CompletedNCT00158860Phase 4
3RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With FamciclovirCompletedNCT00219310Phase 4
4A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus SheddingCompletedNCT00129818Phase 4
5Randomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2CompletedNCT01346475Phase 4
6Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) SheddingCompletedNCT01448616Phase 4
7Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIVCompletedNCT00527618Phase 4
8Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2CompletedNCT00362297Phase 4
9A Randomized Trial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 ReactivationCompletedNCT00723229Phase 4
10VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2CompletedNCT00306293Phase 4
11VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.CompletedNCT00116844Phase 4
12A Randomized Controlled Trial of Acyclovir Among HIV and HSV-2 Co-Infected Women, Chiang Rai, ThailandCompletedNCT00362596Phase 4
13Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding StudyCompletedNCT00464542Phase 4
14Effect of HSV-2 Suppressive Therapy on Sexual BehaviorActive, not recruitingNCT00495716Phase 4
15A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected PersonsTerminatedNCT00079911Phase 4
16A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected PatientsUnknown statusNCT00005663Phase 3
17Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the CommunityUnknown statusNCT00124878Phase 3
18Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital HerpesCompletedNCT00306787Phase 3
19Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital HerpesCompletedNCT00171990Phase 3
20Efficacy of Oral Famciclovir 125mg Comparing to Aciclovir 200 mg Treatment in Patients With Active Recurrent Genital HerpesCompletedNCT01281007Phase 3
21Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes DiseaseCompletedNCT00699764Phase 3
22A Study of Acyclovir to Help Prevent HIV Infection in People With Genital HerpesCompletedNCT00076232Phase 3
23HerpeVac Trial for Young WomenCompletedNCT00057330Phase 3
24Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative SubjectsCompletedNCT00698568Phase 3
25Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV TransmissionCompletedNCT00194519Phase 3
26Valaciclovir to Prevent Transmission of Herpes Simplex VirusCompletedNCT00001649Phase 3
27Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV InfectionCompletedNCT00262106Phase 3
28Open-label Study of ASP2151 in Herpes Simplex PatientsCompletedNCT02209324Phase 3
29Episodic Acyclovir Therapy for Genital UlcersCompletedNCT00164424Phase 2, Phase 3
30HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected PersonsCompletedNCT00465205Phase 3
31HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.CompletedNCT00378976Phase 3
32Effectiveness of a Community-level HIV/STD Prevention Intervention in Promoting Safer Sexual Behaviors in High-risk PopulationsCompletedNCT00710060Phase 3
33Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?Active, not recruitingNCT00860977Phase 3
34Effect of Male Circumcision on HIV Incidence (ANRS 1265)TerminatedNCT00122525Phase 3
35Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal CancerUnknown statusNCT00005025Phase 2
36A Study With ASP2151 in Subjects With Recurrent Episodes of Genital HerpesCompletedNCT00486200Phase 2
37Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV SheddingCompletedNCT00158509Phase 2
38Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Subjects With Recurrent Genital HerpesCompletedNCT01687595Phase 2
39Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2CompletedNCT01047540Phase 2
40Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in AdultsCompletedNCT02030301Phase 1, Phase 2
41Dose Ranging Safety and Efficacy of Therapeutic HSV-2 VaccineCompletedNCT02114060Phase 2
42Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 StudyCompletedNCT02300142Phase 2
43Safety and Immunogenicity Study of Therapeutic HSV-2 VaccineCompletedNCT01667341Phase 1, Phase 2
44Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212)CompletedNCT00158483Phase 2
45Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing.CompletedNCT00740584Phase 1, Phase 2
46Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in UgandaCompletedNCT00405821Phase 2
47HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and BreastfeedingCompletedNCT00530777Phase 2
48Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible MicrobicideCompletedNCT00213031Phase 2
49Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk MelanomaCompletedNCT00273910Phase 2
50BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in WomenCompletedNCT00074425Phase 2

Search NIH Clinical Center for Genital Herpes

Inferred drug relations via UMLS68/NDF-RT46:


Cochrane evidence based reviews: herpes genitalis

Genetic Tests for Genital Herpes

About this section

Anatomical Context for Genital Herpes

About this section

MalaCards organs/tissues related to Genital Herpes:

36
Testes, T cells, Nk cells, B cells, Skin, Myeloid, Cervix

FMA organs/tissues related to Genital Herpes:

17
Genital system, Rectum

Publications for Genital Herpes

About this section

Articles related to Genital Herpes:

(show top 50)    (show all 576)
idTitleAuthorsYear
1
A Comparative Analysis of Polymerase Chain Reaction and Direct Fluorescent Antibody Test for Diagnosis of Genital Herpes. (28042218)
2017
2
Collaboration with a midwife in the care of a pregnant patient with recurrent genital herpes simplex virus. (27412208)
2016
3
Interventions for men and women with their first episode of genital herpes. (27575957)
2016
4
Genital Herpes: What You Should Know. (27281843)
2016
5
Heterogeneous polymer composite nanoparticles loaded in situ gel for controlled release intra-vaginal therapy of genital herpes. (27351137)
2016
6
Serologic Screening for Genital Herpes Infection: US Preventive Services Task Force Recommendation Statement. (27997659)
2016
7
First HSV-1 non primary genital herpes in two patients. (27018573)
2016
8
Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection. (27007679)
2016
9
JAMA patient page: Screening for Genital Herpes. (27997655)
2016
10
Intravaginal Zinc Oxide Tetrapod Nanoparticles as Novel Immunoprotective Agents against Genital Herpes. (27183601)
2016
11
Protection from genital herpes disease, seroconversion and latent infection in a non-lethal murine genital infection model by immunization with an HSV-2 replication-defective mutant virus. (26609935)
2016
12
Metastastic vulvar squamous cell carcinoma mimicking genital herpes. (27752532)
2016
13
Optimal management of genital herpes: current perspectives. (27358569)
2016
14
Attitudes and Willingness to Assume Risk of Experimental Therapy to Eradicate Genital Herpes Simplex Virus Infection. (27513383)
2016
15
Serologic Screening for Genital Herpes: An Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. (27997660)
2016
16
Effects of a traditional Chinese medicine, Longdanxiegan formula granule, on Toll-like receptor pathway in female guinea pigs with recurrent genital herpes. (27125405)
2016
17
Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases. (27766602)
2016
18
Screening for Genital Herpes: What Is Not to Be Done. (27997634)
2016
19
Herpes simplex virus: 'to disclose or not to disclose.' An exploration of the multi-disciplinary team's role in advising patients about disclosure when diagnosed with genital herpes simplex virus. (27582307)
2016
20
Nasal Immunization Confers High Avidity Neutralizing Antibody Response and Immunity to Primary and Recurrent Genital Herpes in Guinea Pigs. (28082979)
2016
21
Evolution of rational vaccine designs for genital herpes immunotherapy. (26896782)
2016
22
Genital herpes. (27109044)
2016
23
Clinical study in genital herpes: natural Gene-Eden-VIR/Novirin versus acyclovir, valacyclovir, and famciclovir. (27621592)
2016
24
Role of type-specific herpes simplex virus-1 and 2 serology as a diagnostic modality in patients with clinically suspected genital herpes: A comparative study in Indian population from a tertiary care hospital. (27510668)
2016
25
OASL1 deficiency promotes antiviral protection against genital herpes simplex virus type 2 infection by enhancing type I interferon production. (26750802)
2016
26
Current Concepts for Genital Herpes Simplex Virus Infection: Diagnostics and Pathogenesis of Genital Tract Shedding. (26561565)
2016
27
Genital Herpes: A Review. (27281837)
2016
28
Integrative pharmacokinetic-pharmacodynamic modeling and simulation of amenamevir (ASP2151) for treatment of recurrent genital herpes. (27461507)
2016
29
A Recommendation Against Serologic Screening for Genital Herpes Infection-What Now? (27997636)
2016
30
Genital Herpes. (27959656)
2016
31
In Situ Detection of Regulatory T Cells in Human Genital Herpes Simplex Virus Type 2 (HSV-2) Reactivation and Their Influence on Spontaneous HSV-2 Reactivation. (27117511)
2016
32
CLINICAL PRACTICE. Genital Herpes. (27532832)
2016
33
Genital Herpes. (27959657)
2016
34
False-negative type-specific glycoprotein G antibody responses in STI clinic patients with recurrent HSV-1 or HSV-2 DNA positive genital herpes, The Netherlands. (26755775)
2016
35
Unfortunate synergy between HIV and genital herpes. (26884529)
2016
36
A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens. (26041292)
2015
37
Non-healing genital herpes mimicking donovanosis in an immunocompetent man. (25614521)
2015
38
Associations between individual and relationship characteristics and genital herpes disclosure. (25814164)
2015
39
Clinical Inquiry: How well do antivirals shorten genital herpes pain duration? (25789347)
2015
40
Oral and Vaginal Tenofovir for Genital Herpes Simplex Virus Type 2 Shedding in Immunocompetent Women: A Double-Blind, Randomized, Cross-over Trial. (26044291)
2015
41
Interferon Lambda 4 Genotype Is Not Associated with Recurrence of Oral or Genital Herpes. (26431156)
2015
42
Intravenous Foscarnet With Topical Cidofovir for Chronic Refractory Genital Herpes in a Patient With AIDS. (26788527)
2015
43
Novel rat models to study primary genital herpes simplex virus-2 infection. (25701211)
2015
44
Molecular diagnostics and newborns at risk for genital herpes simplex virus. (25996200)
2015
45
Erratum to: Diagnosis of genital herpes simplex virus infection in the clinical laboratory. (26463442)
2015
46
Genital herpes: oral antiviral treatments. (25853497)
2015
47
Coping strategies and behavioural changes following a genital herpes diagnosis among an urban sample of underserved Midwestern women. (25792549)
2015
48
Chitosan and Kappa-Carrageenan Vaginal Acyclovir Formulations for Prevention of Genital Herpes. In Vitro and Ex Vivo Evaluation. (26393621)
2015
49
Efficacy of N-methanocarbathymidine against genital herpes simplex virus type 2 shedding and infection in guinea pigs. (26149263)
2015
50
Genital Herpes Simplex Virus Type 2 Shedding Among Adults With and Without HIV Infection in Uganda. (26486633)
2015

Variations for Genital Herpes

About this section

Expression for genes affiliated with Genital Herpes

About this section
Search GEO for disease gene expression data for Genital Herpes.

Pathways for genes affiliated with Genital Herpes

About this section

Pathways related to Genital Herpes according to GeneCards Suite gene sharing:

(show all 22)
idSuper pathwaysScoreTop Affiliating Genes
19.7IL10, IL4
29.7IL10, IL4
39.6IL18, TBX21
49.6IL10, IL18
59.5IL18, TLR2
6
Show member pathways
9.3APOE, CCL5, IL4
79.3IL10, IL4, TLR2
8
Show member pathways
9.3IL10, IL4, TLR2
99.2CCL5, IL18, TLR2
109.2IL10, IL18, TLR2
11
Show member pathways
9.2IL18, IL4, TBX21
129.2IL18, IL4, TBX21
13
Show member pathways
9.2IL10, IL18, IL4
149.2IL10, IL18, IL4
158.9ACKR1, IL10, IL18, TLR2
16
Show member pathways
8.9IL10, IL18, TBX21, TLR2
178.9CCL5, IL10, IL18, IL4
188.9CCL5, IL10, IL18, IL4
198.8IL10, IL18, IL4, TBX21
20
Show member pathways
8.8CCL5, IL18, IL4, TLR2
218.6CCL5, IL10, IL4, TBX21, TLR2
22
Show member pathways
8.4IL10, IL18, IL4, TBX21, TLR2

GO Terms for genes affiliated with Genital Herpes

About this section

Cellular components related to Genital Herpes according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular spaceGO:00056158.0APOE, CCL5, IFNL4, IL10, IL18, IL4

Biological processes related to Genital Herpes according to GeneCards Suite gene sharing:

(show all 19)
idNameGO IDScoreTop Affiliating Genes
1defense response to protozoanGO:004283210.4IL10, IL4
2positive regulation of isotype switching to IgG isotypesGO:004830410.4IL4, TBX21
3negative regulation of endothelial cell apoptotic processGO:200035210.4IL10, IL4
4negative regulation of nitric oxide biosynthetic processGO:004501910.4IL10, IL4
5positive regulation of MHC class II biosynthetic processGO:004534810.4IL10, IL4
6microglial cell activationGO:000177410.3IL4, TLR2
7positive regulation of interleukin-10 productionGO:003273310.3IL4, TLR2
8positive regulation of NF-kappaB import into nucleusGO:004234610.3IL18, TLR2
9positive regulation of activated T cell proliferationGO:004210410.2IL18, IL4
10regulation of isotype switchingGO:004519110.1IL10, IL4
11response to molecule of bacterial originGO:000223710.1IL10, TLR2
12regulation of T cell activationGO:005086310.1CCL5, IFNL4
13lipopolysaccharide-mediated signaling pathwayGO:003166310.0CCL5, IL18, TLR2
14triglyceride homeostasisGO:00703289.7APOE, IL18
15positive regulation of tyrosine phosphorylation of STAT proteinGO:00425319.7CCL5, IL18, IL4
16inflammatory responseGO:00069549.3ACKR1, CCL5, IL10, IL18, TLR2
17immune responseGO:00069559.2CCL5, IL10, IL18, IL4, TLR2
18type 2 immune responseGO:00420929.2IL10, IL18, IL4
19positive regulation of transcription from RNA polymerase II promoterGO:00459448.5IL10, IL18, IL4, T, TLR2

Molecular functions related to Genital Herpes according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cytokine activityGO:00051258.3CCL5, IFNL4, IL10, IL18, IL4

Sources for Genital Herpes

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet